Mirexus Biotechnologies closes $12 mln financing led by GEL
Mirexus Biotechnologies Inc, a Guelph, Ontario biomaterials provider, has raised $12 million in funding. The round was led by the Canadian affiliate of Barbados' Goddard Enterprises Ltd (GEL) and joined by angel members of GreenSky President’s Club, all existing backers of the company. Founded in 2008, Mirexus is commercializing a novel nanotechnology that can be used in markets ranging from cosmetics to nutraceuticals to biomedical applications in animal and human health. Led by President and CEO Phil Whiting, the company will use the funds raised to develop a factory and support operations over the next three years.
4 July 2017•4 mins read
